Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

The furor, which erupted in Ireland last month and then spread quickly across Europe, has led to ready meals being pulled from supermarket shelves and damaged people's confidence in the food on their plate. It also raised concerns over food labeling and the complex supply chain across the European Union, putting pressure on governments to explain lapses in quality control. A fifth of adults said they had started buying less meat after traces of horse DNA were found in some products, according to the poll conducted by Consumer Intelligence research company. "Our findings show that this scandal has really hit consumers hard, be it through having to change their shopping habits or altering the fundamentals of their diet," David Black, a spokesman for Consumer Intelligence, said. The online poll, conducted on February 14-15, questioned more than 2,200 adults on their spending habits following the horsemeat scandal. It gave no specific figures on how much meat people were buying, focusing only on broader trends. More than 65 percent of respondents said they trusted food labels less as a result. "(Brands) will have to put in place really stringent ways of checking that what's being delivered and what's on the label is indeed what's in there," Black said. In the month since horsemeat was first identified in Irish beefburgers, no one is yet reported to have fallen ill from eating horse but many supermarkets and fast food chains are already struggling to save their reputations. Governments across Europe have stressed that horsemeat poses little or no health risk, although some carcasses have been found tainted with a painkiller given to racehorses but banned for human consumption. Environment secretary Owen Paterson, who met British retailers earlier in the day for talks on how to restore consumer confidence, said Britain was closely cooperating with European countries to investigate what happened. "Looking ahead, there was absolute determination in the industry to restore confidence in their products," he said in televised remarks. "We look forward to meeting on a regular basis to absolutely make it clear that when consumers buy a product they get what they bought." British retailers now expect the vast majority of tests on processed beef products to be completed by February 22, according to the British Retail Consortium. More than 60 percent of adults surveyed said they would now buy meat from their local butchers, the poll said, while a quarter of adults said they would now buy more joints, chops or steaks instead of processed meat. Michael Suleyman, who owns a family-run butchers' shop in Brixton, London, said more customers appeared concerned although for now there had not been any difference in sales figures. "We have seen people panicking and asking us lots of questions like 'where do you get your meat from?'," Suleyman, 51, told Reuters. "We assure our customers by showing them the meat and mincing it for them in front of their eyes." But with inflation running above central bank targets and an uncertain job market, the spending power of British consumers has been eroded in recent years and, for some, buying more expensive meat is not an option. Nearly a fifth of respondents said they wanted buy less processed meat such as ready-meals, but could not afford to. At a London branch of Britain's biggest retailer, Tesco, which found horse DNA in some of its own-brand frozen spaghetti bolognese meals last week, consumers were still buying meat products. "I've got nothing against horse meat," said Sean Cosgrove, 39, a local government employee. "I think you're being ambitious if you expect top quality meat in those products anyway."
British shoppers saying nay to meat after horse scandal.

The story provided several estimates for the cost of gastric banding; it also discussed insurance coverage, i.e. that the procedure was not always covered by insurance. While the story mentioned weight loss, health improvement, and longer life, it failed to provide quantitative estimates for these. The story provided quantitative information on the disease reduction obtained with the use of this device in individuals with type II diabetes. Although the story did mention that weight loss is slower with gastric banding than with gastric bypass, itfailed to provide quantitative information about the amount or rate of weight loss attained with banding. The story should also have mentioned that long-term followup finds for those whose diabetes resolves following gastric banding, about half re-develop diabetes at 10 years. The story mentioned weight regain as well as some of the side effects that occur with the use of this device. For a more complete discussion, it should have included information about how frequently these occur. When discussing the effect of gastric banding on type II diabetes, the story mentioned the research about the use of this device for this population. It mentioned the evidence about safety and effectiveness and where it had been published. As for the impact of the banding procedure on weight, the story neglected to include information on the average weight loss seen but did include several patient anecdotes. However the story was more focused on the marketing strategies for this device rather than the health claims per se. The story did not engage in disease mongering. The story included primary quotes from clinicians, industry spokespersons, and individuals who had undergone gastric banding. The story included a pretty comprehensive comparison between gastric banding and gastric bypass, another type of weight loss surgery. It only mentioned diet and exercise in passing and failed to mention medication that can be used for weight loss. The story provided a very complete discussion about the various venues at which gastric banding was available. The story provided a pretty complete history of the use of gastric banding. Does not rely on a press release
Industry Giants Push Obesity Surgery

The storyprovided a morethorough discussion of costs than we have seen in many stories about cosmetic products. It says, "It is, however, expensive: a month's supply of Latisse can cost up to $150, and that is in amounts appropriate for use merely on the eyelashes. Rogaine, which is also available over the counter now, costs about $25 a month, and a month's supply of Propecia runs about $75." The story did not quantify any of the benefits of Latisse or the other hair loss products. The story mentioned harms in passing but did not quantify them. We wish it would have. The problem here is that we are talking about off label use, but, at a minimum, some of the harms related to the other, more established products could have been quantified. Instead, the story gives the harms question short shrift, saying, "One advantage of Latisse is that it needs to be applied only once a day (Rogaine needs to be applied twice; Propecia is taken once daily), and does not seem to cause reactions in people who are allergic to minoxidil." We wish that the story had provided some information about the effectiveness of hair loss products. We only get the one true believer's comment "that (Latisse) has worked for about 70 percent of his patients." We also would have liked to have seen a comment about the need for continuing use of the products. The story does a great job avoiding what may be better termed fear-mongering in a case like this. Often stories about cosmetic medicine make people feel like their aging selves are inadequate. This story actually has a little fun with the idea of men being paranoid about their hair loss without minimizing the very real anxiety that hair loss causes. We did think one comment from Dr. Bernstein seemed to medicalize baldness. He said, that "it's important to remember that baldness is unlike other conditions where you can progress past the point of being helped. Once we have a cure for hair loss, everyone will be able to benefit." We think this one is a wobbler. The story did quote two hair loss specialists. We wish it had gone a little broader in scope and talked with someone who is not currently prescribing Latisse and could speak to the safety and efficacy of an uNPRoven product like this. The story discusses a number of alternatives, and even provides price information for some. It says, for example, "For those too impatient to wait, there is also the bold and fashionable solution of shaving one's head." We do wish, though, that some comparative effectiveness information had been given. The story makes it clear that Latisse is a prescription product sold for eyelashes but being used off label by some doctors for hair loss. The product definitely appears to be novel, and the story does a good job placing it in the right context. The story went well beyond any news release. In fact, unlike other stories we have seen about emerging cosmetic therapies, this story may not be a big hit with the product's manufacturer. The man in thelead anecdote, for example, says that hehas stoppedusing the product because it istoo expensive.
New Stratagems in the Quest for Hair